Paclitaxel (PTX) is used as a viable cancer medication in the chemotherapy of breast, ovarian, lung, bladder, neck, head, and esophageal tumors. The focus of this review is to survey various folate-targeting PTX-loaded nanopreparations in both research and clinical applications. There are diverse nanopreparations, including liposomes, micelles, polymeric nanopreparations, lipid nanopreparations, lipoprotein nanocarriers, and other inorganic nanopreparations for folate-associated PTX tumor targeting. Here, the folate targeting PTX-loaded nanopreparations, which have promising results in the constructive treatment of cancer by reducing toxic side-effects and/or improving effectiveness, was mainly reviewed.
CITATION STYLE
Bawankule, A. K., Tatode, A. A., Patil, P. S., & Umekar, M. J. (2023). Folate-Mediated Paclitaxel Nanodelivery Systems: A Comprehensive Review. Turkish Journal of Pharmaceutical Sciences. Turkish Pharmacists Association. https://doi.org/10.4274/tjps.galenos.2021.26529
Mendeley helps you to discover research relevant for your work.